Glycosylated platinum(iv) prodrugs demonstrated significant therapeutic efficacy in cancer cells and minimized side-effects
Author:
Affiliation:
1. College of Pharmacy
2. State Key Laboratory of Elemento-organic Chemistry
3. Nankai University
4. Tianjin 300071
5. P. R. China
Abstract
Conjugates (A1–A5) of the Pt(iv) derivative (A6) with amino groups from peracetyl glucose, rhamnose and mannose with a propyl amino or ethyl amino linker at the reducing end were synthesized and exhibited significant therapeutic efficacy in tumour cells, especially for prostate cancer (PCa).
Publisher
Royal Society of Chemistry (RSC)
Subject
Inorganic Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2016/DT/C6DT02207C
Reference49 articles.
1. Cellular processing of platinum anticancer drugs
2. The resurgence of platinum-based cancer chemotherapy
3. Cisplatin (cis-diamminedichloroplatinum II)
4. Platinum Group Antitumor Chemistry: Design and development of New Anticancer Drugs Complementary to Cisplatin
5. The status of platinum anticancer drugs in the clinic and in clinical trials
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cyclodextrin-based supramolecular nanogels decorated with mannose for short peptide encapsulation;International Journal of Pharmaceutics;2024-07
2. 2D and 3D anticancer properties of C2-functionalised glucosamine-Pt (IV) prodrugs based on cisplatin scaffold;Frontiers in Chemistry;2024-05-06
3. Pt(IV) Complexes in the Search for Novel Platinum Prodrugs with Promising Activity;Topics in Current Chemistry;2024-02-24
4. Homo and heterometallic ruthenium and platinum complexes with multiple targets for therapeutic applications: a review;Reviews in Inorganic Chemistry;2023-05-12
5. Development of Novel Pt(IV)-Carbohydrate Derivatives as Targeted Anticancer Agents against Osteosarcoma;International Journal of Molecular Sciences;2023-03-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3